MABPHARM B (Hong Kong) Profile

Performance

   

Odds of Distress

75%75%
Check how we calculate scores
Equity ratings for MABPHARM B are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting July 19, 2019 and ending today October 17, 2019. Click here to learn more.
MABPHARM B cannot be verified against its exchange. It appears MABPHARM B is not available for investing at the moment. Please verify the symbol is currently traded on Hong Kong Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

MABPHARM B Profile

Mabpharm Limited, a biopharmaceutical company, focuses on the research, development, and production of drugs and biosimilar drugs for cancers and autoimmune diseases in China. The company was founded in 2018 and is headquartered in Taizhou, China. MABPHARM B is traded on Hong Kong Stock Exchange in Hong Kong.. The public information regarding MABPHARM B's current market price is not available at this time.
NameMABPHARM B
Macroaxis Advice
InstrumentHong Kong Stock View All
Business AddressBlock G79
ExchangeHong Kong Stock Exchange
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.mabpharm.cn
CurrencyHKD
Next Fiscal Year EndDecember 31, 2020
Last Fiscal Year EndDecember 31, 2018
MABPHARM B (2181) is traded on Hong Kong Stock Exchange in Hong Kong and employs 250 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 5.2 B. MABPHARM B operates under Healthcare sector and is part of Biotechnology industry. The entity has 4.12 B outstanding shares.
Check MABPHARM B Probability Of Bankruptcy

MABPHARM B Key Fundamentals

MABPHARM B Against Markets

MABPHARM B cannot be verified against its exchange. It appears MABPHARM B is not available for investing at the moment. Please verify the symbol is currently traded on Hong Kong Stock Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

Mabpharm Limited, a biopharmaceutical company, focuses on the research, development, and production of drugs and biosimilar drugs for cancers and autoimmune diseases in China. The company was founded in 2018 and is headquartered in Taizhou, China. MABPHARM B is traded on Hong Kong Stock Exchange in Hong Kong.. The public information regarding MABPHARM B's current market price is not available at this time.
NameMABPHARM B
Macroaxis Advice
InstrumentHong Kong Stock View All
Business AddressBlock G79
ExchangeHong Kong Stock Exchange
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.mabpharm.cn
CurrencyHKD
Next Fiscal Year EndDecember 31, 2020
Last Fiscal Year EndDecember 31, 2018
See also Trending Equities. Please also try Bollinger Bands module to use bollinger bands indicator to analyze target price for a given investing horizon.
Search macroaxis.com